[MDGL] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -31.42%
YoY- -136.96%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -57,518 -52,546 -36,135 -15,080 -6,364 -5,999 -6,524 43.70%
Tax 69 -160 0 0 0 0 0 -
NP -57,587 -52,546 -36,135 -15,080 -6,364 -5,999 -6,524 43.73%
Tax Rate - - - - - - - -
Total Cost 57,587 52,546 36,135 15,080 6,364 5,999 6,524 43.73%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -3.37 -3.32 -2.34 -0.98 -0.45 -0.50 -37.03 -32.92%
EPS Diluted -3.37 -3.32 -2.34 -0.98 -0.45 -0.50 -37.03 -32.92%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.